| Preface | 5 |
|---|
| Contents | 7 |
|---|
| Contributors | 9 |
|---|
| Human Cytomegalovirus Genome | 14 |
|---|
| Introduction | 15 |
| Genome Organization and cis -Acting Elements | 16 |
| Clinical Isolates and Laboratory Strains | 17 |
| Protein-Coding ORFs | 19 |
| Genomic Organization: Evolution and Function | 29 |
| Perspectives | 30 |
| References | 30 |
| Human Cytomegalovirus microRNAs | 34 |
|---|
| Introduction | 35 |
| miRNA Biogenesis | 36 |
| Location and Conservation of HCMV miRNAs | 40 |
| HCMV miRNA Expression | 44 |
| Potential Function of HCMV miRNAs | 47 |
| Future Directions | 48 |
| References | 48 |
| Mutagenesis of the Cytomegalovirus Genome | 54 |
|---|
| Introduction | 55 |
| CMV Genetics in Cells | 55 |
| CMV Genetics in Bacteria | 58 |
| Genetic Analysis of Essential Genes | 66 |
| Concluding Remarks | 70 |
| References | 70 |
| Cytomegalovirus Cell Tropism | 76 |
|---|
| Target Cells of HCMV Infection | 77 |
| Pathogenetic Role of Selected Cell Types | 81 |
| Cell Biological Basis of HCMV Cell Tropism | 86 |
| Cell Tropism of Other Cytomegaloviruses | 89 |
| Impact of Cell Tropism Analyses | 90 |
| References | 91 |
| Virus Entry and Innate Immune Activation | 98 |
|---|
| Introduction to Virus Entry | 99 |
| Cellular Receptors Proposed for HCMV Entry | 99 |
| Envelope and Membrane Fusion | 103 |
| Introduction to Activation of Innate Immunity | 104 |
| Activation of Inflammatory Cytokines | 104 |
| Activation of Interferon Responses | 106 |
| Coordination of Entry Events and Innate Immune Activation Steps | 107 |
| Perspectives | 109 |
| References | 109 |
| Functions of Human Cytomegalovirus Tegument Proteins Prior to Immediate Early Gene Expression | 114 |
|---|
| Introduction | 114 |
| Tegument Proteins Known to Act at the Very Start of HCMV Infection | 117 |
| Delivery of the Genome to the Nucleus | 118 |
| Initiating Viral IE Gene Expression | 120 |
| Model for Postfusion, Preimmediate Early Events | 123 |
| Perspectives | 124 |
| References | 125 |
| Initiation of Cytomegalovirus Infection at ND10 | 130 |
|---|
| Structural Observations in the First Hours After CMV Infection and Their Limits in Interpretative Value | 131 |
| Are ND10 Really the Start Sites of CMV Transcription? | 134 |
| Structural and Functional Aspects of IE1 | 135 |
| IE1 Counteracts the Host Cell s Silencing Mechanisms | 136 |
| Effect of ND10-Associated Proteins on CMV | 138 |
| Perspectives | 141 |
| References | 142 |
| Functional Roles of the Human Cytomegalovirus Essential IE86 Protein | 146 |
|---|
| Introduction | 146 |
| Mapping the Functional Domains of the IE86 Protein | 148 |
| Autoregulation of the MIE Promoter | 152 |
| Transcription from Viral and Cellular Promoters | 153 |
| Cell Cycle Progression | 155 |
| Perspectives | 158 |
| References | 159 |
| Nuts and Bolts of Human Cytomegalovirus Lytic DNA Replication | 166 |
|---|
| Introduction | 167 |
| Essential Region I: IE2-UL84 Responsive Promoter in oriLyt | 168 |
| Essential Region II: RNA/DNA Hybrid Structure | 171 |
| Viral-Encoded trans -Acting Factors Required for Lytic Replication | 172 |
| UL84 and IE2 | 174 |
| Viral and Cellular Encoded UL84 Binding Partners | 175 |
| Summary and Perspectives | 176 |
| References | 176 |
| Interactions of Human Cytomegalovirus Proteins with the Nuclear Transport Machinery | 180 |
|---|
| Introduction | 181 |
| Nuclear Import and Export Pathways | 182 |
| Interaction of the Human Cytomegalovirus Protein pUL69 with the mRNA Export Factor UAP56 | 186 |
| RNA Export by pUL69 | 189 |
| Interaction of the HCMV pUL84 with Importin-a Proteins | 191 |
| Unconventional Interactions with the Nuclear Transport Machinery: Novel Targets for Antiviral Strategies? | 192 |
| References | 193 |
| Structure and Formation of the Cytomegalovirus Virion | 200 |
|---|
| Introduction | 200 |
| Formation of the Nucleocapsid | 203 |
| Tegumentation and Envelopment | 209 |
| Concluding Thoughts | 212 |
| References | 212 |
| Human Cytomegalovirus Modulation of Signal Transduction | 218 |
|---|
| Introduction | 219 |
| Signaling Overview | 220 |
| Biological Rationale for Modulation of Host Cell Signaling | 225 |
| Role of Signaling in Pathogenesis | 228 |
| Final Thoughts | 228 |
| References | 229 |
| Chemokines and Chemokine Receptors Encoded by Cytomegaloviruses | 234 |
|---|
| Introduction | 235 |
| Evolution of CMV vCK Genes | 236 |
| Chemokine Receptors Encoded by CMVs | 240 |
| Perspectives | 250 |
| References | 250 |
| Subversion of Cell Cycle Regulatory Pathways | 256 |
|---|
| The Host Cell Cycle | 256 |
| The Effect of HCMV on the Cell Cycle | 259 |
| Importance of Subversion of the Cell Cycle for the Viral Infection | 261 |
| Perspectives | 269 |
| References | 270 |
| Modulation of Host Cell Stress Responses by Human Cytomegalovirus | 276 |
|---|
| Introduction | 277 |
| Background: PI3K-Akt-TSC-mTOR Signaling | 278 |
| Background: The Complexes of mTOR Kinase and Their Activities | 279 |
| HCMV and the Activation of the PI3K-Akt-TSC-mTORC1 Pathway | 281 |
| The Effects of HCMV Downstream of Akt | 284 |
| HCMV Effects on the mTOR Complexes and Their Substrates | 285 |
| HCMV Effects on eIF4E and Mnk-1 | 286 |
| Conclusions, Questions, Speculations | 287 |
| References | 289 |
| Control of Apoptosis by Human Cytomegalovirus | 294 |
|---|
| Introduction | 295 |
| vMIA Controls Mitochondria-Dependent Death | 296 |
| vICA Controls Caspase-8 | 300 |
| IE1 491aa , IE2 579aa , and Akt-Dependent Pro-survival Pathways | 300 |
| UL38 Decreases Intrinsic Stress | 301 |
| M45 Is a Cell Type-Specific Survival Factor | 302 |
| m41, Late Infection, and the Golgi Apparatus | 303 |
| ß2.7 and Mitochondrial Respiratory Complex I | 303 |
| Summary and Perspectives | 303 |
| References | 304 |
| Aspects of Human Cytomegalovirus Latency and Reactivation | 310 |
|---|
| Introduction | 311 |
| Latency, Carriage and Reactivation of HCMV in the Cells of the Myeloid Lineage | 311 |
| Models of HCMV Latency Using Experimental Infection | 313 |
| Viral Gene Expression Associated with HCMV Latency | 314 |
| Key Aspects of HCMV Latency and Reactivation | 315 |
| Other Sites
|